Investment Summary |
|
|---|---|
| Date | 2015-05-26 |
| Target | AirXpanders |
| Sector | Medical Products |
| Investor(s) | Vivo Capital |
| Deal Type | PIPE |
SEARCH BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 1996 |
| PE ASSETS | 6.4B USD |
| Size | Mega |
| Type | Sector Focused |
Vivo Capital is a healthcare investment firm focused on opportunities throughout the US and China. Specific areas of interest include biopharmaceuticals, specialty pharmaceuticals, and medical devices. The Firm looks to identify and work with companies at the development and commercial stage products in the US and at the revenue stage in China. Vivo Capital was established in 1997 and is headquartered in Palo Alto, California.
| DEAL STATS | # |
|---|---|
| Overall | 7 of 18 |
| Sector: Medical Products M&A | 3 of 5 |
| Type: PIPE M&A Deals | 2 of 2 |
| State: California M&A | 4 of 6 |
| Country: United States M&A | 6 of 15 |
| Year: 2015 M&A | 4 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-04-07 |
Nabriva Therapeutics
Dublin, Ireland Nabriva Therapeutics is a clinical-stage biopharmaceutical company engaged in research and development of innovative anti-infective agents to treat serious infections. Nabriva Therapeutics was founded in 2005 and is based in Dublin, Ireland. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-09-23 |
Nabriva Therapeutics
Dublin, Ireland Nabriva Therapeutics is a clinical-stage biopharmaceutical company engaged in research and development of innovative anti-infective agents to treat serious infections. Nabriva Therapeutics was founded in 2005 and is based in Dublin, Ireland. |
Sell | - |
